Exact Mass: 478.2598
Exact Mass Matches: 478.2598
Found 230 metabolites which its exact mass value is equals to given mass value 478.2598
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(1R,4R,5R,8R,9S)-9-formyl-5-methyl-13-propan-2-yl-2-[[(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]tetracyclo[7.4.0.02,11.04,8]tridec-12-ene-1-carboxylic acid
Diflucortolone valerate
Mosapramine
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics
[2-(6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 2,2-dimethylpropanoate
(2R,4aR,5S,6R,6aS,10aR,10bR)-6-(acetyloxy)-4a,6a,10b-trimethyl-5-oxo-decahydro-1H-dispiro[oxirane-2,7-naphtho[2,1-b]pyran-3,3-oxolane]-5-yl 2-methylpropanoate
methyl-ent-1alpha-(2-methyl-2,3-epoxybutyryloxy)-7alpha,9alpha,15alpha-trihydroxykaur-16-en-19-oate|methyl-ent-1alpha-<2-methyl-2,3-epoxybutyryloxy>-7alpha,9alpha,15alpha-trihydroxykaur-16-en-19-oate
12-amino-6-benzyl-9-sec-butyl-15-methoxy-4,7,10-triaza-bicyclo[12.3.1]octadeca-1(18),2,14,16-tetraene-5,8,11-trione|Mucronine H
1,6-di-O-acetyl-9-deoxyforskolin|8,13-epoxy-1alpha,6beta,7beta-triacetoxylabd-14-en-11-one
7alpha,12alpha,14beta,15beta-tetrahydroxy-3beta,19-diacetoxy-ent-kaur-16-ene 7,14-acetal|pharicinin D acetal
(1R*,4R*,5R*,6R*)-1,4,5-tris(acetyloxy)-9-{[(2Z)-2-methylbut-2-enoyl]oxy}bisabol-2(3),10(11)-diene|3-methyl-1-{2-[(1R*,2R*,5R*,6S*)-2,5,6-tris(acetyloxy)-4-methylcyclohex-3-en-1-yl]propyl}but-2-enyl (2Z)-2-methylbut-2-enoate
19-hydroxyspruceanol 19-O-beta-D-glucopyranoside|[(1R,2R,4aR,10aS)-8-ethenyl-1,2,3,4,4a,9,10,10a-octahydro-2,6-dihydroxy-1,4a,7-trimethylphenanthren-1-yl]methyl-beta-D-glucopyranoside
2,10,14-triacetoxy-7,8,18,19-diepoxydolabell-3(E)-ene|2alpha,10alpha,14alpha-triacetoxy-7,8,18,19-diepoxydolabell-3(E)-ene
5alpha-hydroxy-9alpha,10beta,13alpha-triacetoxy-11(15->1)-abeo-taxa-4(20),11-diene
2beta,3alpha,15beta-Triacetoxy-7beta,8beta,14alpha,(16)-diepoxy-ent-pimarane
Phe Ala Asn Lys
C26H38O8_(4aR,5S,6R,6aS,7R,10aR,10bR)-6-Acetoxy-4a,6a,10b-trimethyl-5-oxododecahydro-2H-dispiro[furan-3,3-benzo[f]chromene-7,2-oxiran]-5-yl 2-methylpropanoate
C26H38O8_(2E)-5-(3-Acetoxy-6-hydroxy-5,5,8a-trimethyl-2-methylene-4-oxodecahydro-1-naphthalenyl)-3-methyl-2-pentene-1,4-diyl diacetate
C26H38O8_1H-Benz[e]indene-6-propanoic acid, dodecahydro-2-hydroxy-7-(1-hydroxy-1-methylethyl)-9b-(methoxycarbonyl)-2,3a,6,9a-tetramethyl-4-methylene-1,3-dioxo
C26H38O8_1H-Naphtho[1,2-c]pyran-7-propanoic acid, dodecahydro-8-(1-hydroxy-1-methylethyl)-3-(methoxycarbonyl)-3,4a,7,10a-tetramethyl-5-methylene-1,4-dioxo
Ala Phe Lys Asn
Ala Phe Asn Lys
Ala Lys Phe Asn
Ala Lys Asn Phe
Ala Asn Phe Lys
Ala Asn Lys Phe
Cys Lys Lys Thr
Cys Lys Thr Lys
Cys Thr Lys Lys
Phe Ala Lys Asn
Phe Gly Lys Gln
Phe Gly Gln Lys
Phe Lys Ala Asn
Phe Lys Gly Gln
Phe Lys Asn Ala
Phe Lys Gln Gly
Phe Asn Ala Lys
Phe Asn Lys Ala
Phe Gln Gly Lys
Phe Gln Lys Gly
Gly Phe Lys Gln
Gly Phe Gln Lys
Gly Lys Phe Gln
Gly Lys Gln Phe
Gly Gln Phe Lys
Gly Gln Lys Phe
Lys Ala Phe Asn
Lys Ala Asn Phe
Lys Cys Lys Thr
Lys Cys Thr Lys
Lys Phe Ala Asn
Lys Phe Gly Gln
Lys Phe Asn Ala
Lys Phe Gln Gly
Lys Gly Phe Gln
Lys Gly Gln Phe
Lys Lys Cys Thr
Lys Lys Thr Cys
Lys Asn Ala Phe
Lys Asn Phe Ala
Lys Gln Phe Gly
Lys Gln Gly Phe
Lys Thr Cys Lys
Lys Thr Lys Cys
Asn Ala Phe Lys
Asn Ala Lys Phe
Asn Phe Ala Lys
Asn Phe Lys Ala
Asn Lys Ala Phe
Asn Lys Phe Ala
Gln Phe Gly Lys
Gln Phe Lys Gly
Gln Gly Phe Lys
Gln Gly Lys Phe
Gln Lys Phe Gly
Gln Lys Gly Phe
Thr Cys Lys Lys
Thr Lys Cys Lys
Thr Lys Lys Cys
8-(4-{[(3S)-5-Methoxy-3,4-dihydro-2H-chromen-3-yl](propyl)amino}b utyl)-8-azaspiro[4.5]decane-7,9-dione hydrochloride (1:1)
N-[5-(2-methoxy-2-phenylacetyl)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
Diflucortolone pivalate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
mosapramine
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics
(1R,2S,4R,5R,8R,9S,11S)-9-formyl-5-methyl-13-propan-2-yl-2-[[(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]tetracyclo[7.4.0.02,11.04,8]tridec-12-ene-1-carboxylic acid
3-(4-morpholinyl)-N-[11-[2-(4-morpholinyl)-1-oxoethyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]propanamide
4-O-Demethylsordarin
A tetracyclic diterpenoid consisting of sordaricin in which the primary hydroxy hydrogen has been replaced by a 6-deoxy-beta-D-altropyranosyl group.
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide
N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-(3-pyridinylmethyl)-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-methoxyethanone
2-(dimethylamino)-1-[(1R)-1-(hydroxymethyl)-7-methoxy-1-(5-pyrimidinylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide
N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-(3-pyridinylmethyl)-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-methoxyethanone
2-(dimethylamino)-1-[(1S)-1-(hydroxymethyl)-7-methoxy-1-(5-pyrimidinylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
(1R)-1-(hydroxymethyl)-7-methoxy-2-[(3-methoxyphenyl)methyl]-N-propyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
(1-butanoyloxy-3-phosphonooxypropan-2-yl) (Z)-hexadec-9-enoate
(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (Z)-tridec-9-enoate
(1-hexanoyloxy-3-phosphonooxypropan-2-yl) (Z)-tetradec-9-enoate
(1-phosphonooxy-3-propanoyloxypropan-2-yl) (Z)-heptadec-9-enoate
(1-acetyloxy-3-phosphonooxypropan-2-yl) (Z)-octadec-9-enoate
(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (Z)-pentadec-9-enoate
Didecanoylphosphatidate(2-)
A phosphatidate(2-) obtained by deprotonation of both phosphate OH groups of didecanoylphosphatidic acid; major species at pH 7.3.
1,2-Dicapryl-sn-glycero-3-phosphate(2-)
A 1,2-diacyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1,2-dicapryl-sn-glycero-3-phosphate; major species at pH 7.3.
BisMePA(18:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,2s,3s,4r,8s,9s,12r)-2-formyl-4,8-dimethyl-13-methylidenetetracyclo[10.2.1.0¹,⁹.0³,⁸]pentadecane-4-carboxylate
(4s,6s)-2-methyl-6-[(1r,2s,5r,6s)-2,5,6-tris(acetyloxy)-4-methylcyclohex-3-en-1-yl]hept-2-en-4-yl (2z)-2-methylbut-2-enoate
1-[4-(acetyloxy)-5-[(acetyloxy)methyl]-1,2,5-trimethyl-6-oxo-3,4,7,8-tetrahydro-2h-naphthalen-1-yl]-3-hydroxy-3-methylpent-4-en-1-yl acetate
(3r,4as,5s,6s,6as,10s,10as,10br)-6,10-bis(acetyloxy)-3-ethenyl-3,4a,7,7,10a-pentamethyl-1-oxo-octahydronaphtho[2,1-b]pyran-5-yl acetate
(1s,2r,5r,10r,11r,12s,16s,17r,20s,21s,22r)-8-isopropyl-12-methoxy-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricosa-8,13-diene-11,16,17,21-tetrol
2-(acetyloxy)-18-hydroxy-5,5,9-trimethyl-14-oxo-15,17-dioxapentacyclo[11.5.1.0¹,¹⁰.0⁴,⁹.0¹⁶,¹⁹]nonadecan-3-yl butanoate
7-ethenyl-1,4a,7-trimethyl-1-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-4,4b,5,6,10,10a-hexahydro-3h-phenanthrene-2,9-dione
[(1as,1bs,3r,3ar,5s,7br,9r,9ar)-3,9-bis(acetyloxy)-5-[(1r)-1,2-dihydroxyethyl]-5,7b-dimethyl-1h,1bh,2h,3h,3ah,4h,6h,8h,9h,9ah-cyclopropa[a]phenanthren-1a-yl]methyl acetate
(1s,4as,7s,10ar)-7-ethenyl-1,4a,7-trimethyl-1-({[(2r,3s,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-4,5,6,8,10,10a-hexahydro-3h-phenanthrene-2,9-dione
2,13-bis(acetyloxy)-4,9,12-trimethyl-15-(2-methyloxiran-2-yl)-5-oxatricyclo[10.3.0.0⁴,⁶]pentadec-9-en-11-yl acetate
(1r,2s,3s,4r,7s,8s,9s,12z,14s,17s)-7-(acetyloxy)-2,4-dihydroxy-4,8,12,17-tetramethyl-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadeca-5,12-dien-9-yl butanoate
(1s,4ar,4br,7r,10ar)-7-ethenyl-1,4a,7-trimethyl-1-({[(2r,3s,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-4,4b,5,6,10,10a-hexahydro-3h-phenanthrene-2,9-dione
2-deacetyldecinnamoyltaxinine e
{"Ingredient_id": "HBIN005506","Ingredient_name": "2-deacetyldecinnamoyltaxinine e","Alias": "NA","Ingredient_formula": "C26H38O8","Ingredient_Smile": "CC1=C2C(C(C3(CCC(C(=C)C3C(C(C2(C)C)CC1OC(=O)C)O)O)C)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4736","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-methyl-1-{2-[(1r*,2s*,5r*,6r*)-2,5,6-tri(acetyloxy)-4-methyl-3-cyclohexenyl]-pro-pyl}-2-butenyl(z)-2-methyl-2-butenoate
{"Ingredient_id": "HBIN008861","Ingredient_name": "3-methyl-1-{2-[(1r*,2s*,5r*,6r*)-2,5,6-tri(acetyloxy)-4-methyl-3-cyclohexenyl]-pro-pyl}-2-butenyl(z)-2-methyl-2-butenoate","Alias": "NA","Ingredient_formula": "C26H38O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14759","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
adenanthin b
{"Ingredient_id": "HBIN014673","Ingredient_name": "adenanthin b","Alias": "NA","Ingredient_formula": "C26H38O8","Ingredient_Smile": "CC(=O)OC1CC2CC3(C1C4(C(CC3OC(=O)C)C(C(CC4OC(=O)C)O)(C)C)C)C(C2=C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "606","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}